Aptamer for periostin and anti-cancer composition including same
US9650638B2 · kind B2 · utility
1Cited by
1References
12Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Nov 12, 2012 |
| Grant date | May 16, 2017 |
| Priority date | — |
| Expiry date | Dec 9, 2032 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2333/705
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This disclosure relates to DNA aptamer specifically binding to periostin, which is cancer-related protein, a composition for inhibiting cancer and/or cancer metastasis and/or a composition for diagnosis of cancer and/or cancer metastasis, comprising the same as an active ingredient, wherein the aptamer has different binding mechanism from the existing antibodies, and thus, may inhibit and diagnose cancer/cancer metastasis more effectively.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.